Search Ontology:
ChEBI

beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp

Term ID
CHEBI:62311
Synonyms
  • beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
  • beta-D-galactosyl-(1->3)-N-acetyl-D-glucosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucoose
  • beta-D-glucopyranose, O-beta-D-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-
  • Galb1-3GalNAcb1-3Gala1-4Galb1-4Glcb
  • Galbeta1,3GalNAcbeta1,3Galalpha1,4Galbeta1,4Glcbeta
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta
  • O-beta-D-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
Definition
A linear amino pentasaccharide comprising β-D-glucose at the reducing end with a β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl moiety at the 4-position. β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-D-Glcp in which the anomeric configuration of the glucose residue at the reducing end is β.
References
  • glygen:G99053DY
  • glytoucan:G99053DY
  • pubmed:18773292
  • pubmed:19443021
  • pubmed:25568069
  • pubmed:31537530
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype affecting beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp
Human Disease Model